Choreo LLC Raises Position in Intuitive Surgical, Inc. $ISRG

Choreo LLC boosted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.4% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 12,341 shares of the medical equipment provider’s stock after purchasing an additional 737 shares during the period. Choreo LLC’s holdings in Intuitive Surgical were worth $6,706,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. Correct Capital Wealth Management lifted its stake in shares of Intuitive Surgical by 66.7% in the 2nd quarter. Correct Capital Wealth Management now owns 500 shares of the medical equipment provider’s stock valued at $163,000 after acquiring an additional 200 shares during the last quarter. J.W. Cole Advisors Inc. increased its stake in Intuitive Surgical by 232.7% in the 2nd quarter. J.W. Cole Advisors Inc. now owns 22,102 shares of the medical equipment provider’s stock worth $12,010,000 after purchasing an additional 15,459 shares during the period. North Star Asset Management Inc. lifted its position in Intuitive Surgical by 2.0% in the second quarter. North Star Asset Management Inc. now owns 22,379 shares of the medical equipment provider’s stock valued at $12,161,000 after purchasing an additional 448 shares during the last quarter. FourThought Financial Partners LLC purchased a new stake in shares of Intuitive Surgical during the second quarter valued at approximately $213,000. Finally, Associated Banc Corp purchased a new stake in shares of Intuitive Surgical during the second quarter valued at approximately $309,000. 83.64% of the stock is owned by institutional investors.

Insider Buying and Selling

In related news, CEO David J. Rosa sold 24,500 shares of Intuitive Surgical stock in a transaction that occurred on Friday, October 24th. The stock was sold at an average price of $547.55, for a total transaction of $13,414,975.00. Following the sale, the chief executive officer directly owned 234,256 shares in the company, valued at $128,266,872.80. The trade was a 9.47% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Brian Edward Miller sold 3,500 shares of the stock in a transaction on Monday, November 10th. The stock was sold at an average price of $575.00, for a total value of $2,012,500.00. Following the completion of the transaction, the executive vice president owned 5,758 shares of the company’s stock, valued at approximately $3,310,850. This trade represents a 37.81% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 116,164 shares of company stock worth $61,916,172 over the last quarter. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG opened at $574.23 on Thursday. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $616.00. The company’s 50-day moving average is $500.48 and its 200 day moving average is $504.89. The stock has a market capitalization of $205.85 billion, a P/E ratio of 75.96, a P/E/G ratio of 4.94 and a beta of 1.62.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, topping the consensus estimate of $1.99 by $0.41. The business had revenue of $2.51 billion during the quarter, compared to analyst estimates of $2.41 billion. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. Intuitive Surgical’s quarterly revenue was up 22.9% compared to the same quarter last year. During the same period last year, the business posted $1.84 earnings per share. Research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of research firms recently commented on ISRG. The Goldman Sachs Group upped their price target on shares of Intuitive Surgical from $567.00 to $621.00 and gave the company a “buy” rating in a report on Wednesday, October 22nd. UBS Group set a $600.00 price objective on shares of Intuitive Surgical and gave the company a “neutral” rating in a research report on Thursday, October 23rd. Piper Sandler increased their target price on shares of Intuitive Surgical from $595.00 to $610.00 and gave the stock an “overweight” rating in a report on Wednesday, October 22nd. Wall Street Zen raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Saturday, November 22nd. Finally, Hsbc Global Res raised Intuitive Surgical to a “strong-buy” rating in a research report on Thursday, October 23rd. Two investment analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus price target of $608.92.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.